My name is Savita Sankar, and, I am a Senior Principal Scientist & Group Leader at Pfizer Inc. in St. Louis, Missouri. I have been working at Pfizer for five years and my work is focused on AAV-gene therapies, particularly, on developing, qualifying, and validating, cell-based potency assays for gene therapies. Prior to working at Pfizer, I obtained my PhD from the University of Utah in Salt Lake City in the field of Molecular and Cellular Biology and did post-doctoral research work at Harvard Medical School in Boston where I worked on mechanisms of drug resistance in tumors, and, at Washington University in St. Louis where I worked on mechanistic differences in gene regulation between normal brain development and in brain tumors.